• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用两个不同的癌症登记系统确定德克萨斯州皮肤T细胞淋巴瘤的地理聚集情况及未受影响的区域。

Identification of geographic clustering and regions spared by cutaneous T-cell lymphoma in Texas using 2 distinct cancer registries.

作者信息

Litvinov Ivan V, Tetzlaff Michael T, Rahme Elham, Habel Youssef, Risser David R, Gangar Pamela, Jennings Michelle A, Pehr Kevin, Prieto Victor G, Sasseville Denis, Duvic Madeleine

机构信息

Division of Dermatology, McGill University Health Centre, Montreal, Quebec, Canada.

Section of Dermatopathology, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

出版信息

Cancer. 2015 Jun 15;121(12):1993-2003. doi: 10.1002/cncr.29301. Epub 2015 Feb 27.

DOI:10.1002/cncr.29301
PMID:25728286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4457714/
Abstract

BACKGROUND

Cutaneous T-cell lymphomas (CTCLs) (mycosis fungoides and its leukemic variant, Sezary syndrome) are rare malignancies. Reports of the occurrence of mycosis fungoides in married couples and families raise the possibility of an environmental trigger for this cancer. Although it has been suggested that CTCL arises from inappropriate T-cell stimulation, to the authors' knowledge no preventable trigger has been identified to date.

METHODS

Using region, zip code, age, sex, and ethnicity, the authors analyzed the demographic data of 1047 patients from Texas who were seen in a CTCL clinic at The University of Texas MD Anderson Cancer Center during 2000 through 2012 (the MDACC database) and 1990 patients who were recorded in the population-based Texas Cancer Registry between 1996 and 2010. Subsequently, data from both databases were cross-analyzed and compared.

RESULTS

The current study findings, based on the MDACC database, documented geographic clustering of patients in 3 communities within the Houston metropolitan area, in which CTCL incidence rates were 5 to 20 times higher than the expected population rate. Analysis of the Texas Cancer Registry database defined the CTCL population rate for the state to be 5.8 cases per million individuals per year (95% confidence interval, 5.5-6.0 per million individuals per year), thus confirming the observations from the MDACC database and further highlighting additional areas of geographic clustering and regions spared from CTCL in Texas.

CONCLUSIONS

The current study documented geographic clustering of CTCL cases in Texas and argued for the existence of yet unknown external causes/triggers for this rare malignancy.

摘要

背景

皮肤T细胞淋巴瘤(CTCLs)(蕈样肉芽肿及其白血病变异型,Sezary综合征)是罕见的恶性肿瘤。关于蕈样肉芽肿在已婚夫妇和家庭中发生的报道增加了这种癌症存在环境触发因素的可能性。尽管有人提出CTCL起源于不适当的T细胞刺激,但据作者所知,迄今为止尚未确定可预防的触发因素。

方法

作者利用地区、邮政编码、年龄、性别和种族,分析了2000年至2012年期间在德克萨斯大学MD安德森癌症中心CTCL诊所就诊的1047名德克萨斯患者的人口统计学数据(MDACC数据库),以及1996年至2010年期间记录在基于人群的德克萨斯癌症登记处的1990名患者的数据。随后,对两个数据库的数据进行交叉分析和比较。

结果

基于MDACC数据库的当前研究结果记录了休斯顿大都市地区3个社区患者的地理聚集情况,其中CTCL发病率比预期人群发病率高5至20倍。对德克萨斯癌症登记处数据库的分析确定该州CTCL人群发病率为每年每百万人口5.8例(95%置信区间,每年每百万人口5.5 - 6.0例),从而证实了MDACC数据库的观察结果,并进一步突出了德克萨斯州地理聚集的其他区域以及未受CTCL影响的区域。

结论

当前研究记录了德克萨斯州CTCL病例的地理聚集情况,并认为这种罕见恶性肿瘤存在尚未知晓的外部原因/触发因素。

相似文献

1
Identification of geographic clustering and regions spared by cutaneous T-cell lymphoma in Texas using 2 distinct cancer registries.利用两个不同的癌症登记系统确定德克萨斯州皮肤T细胞淋巴瘤的地理聚集情况及未受影响的区域。
Cancer. 2015 Jun 15;121(12):1993-2003. doi: 10.1002/cncr.29301. Epub 2015 Feb 27.
2
Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy.对加拿大皮肤 T 细胞淋巴瘤 (CTCL) 的发病率和死亡率进行全面分析,揭示了这种恶性肿瘤的变化趋势和地域聚集性。
Cancer. 2017 Sep 15;123(18):3550-3567. doi: 10.1002/cncr.30758. Epub 2017 May 10.
3
Demographic patterns of cutaneous T-cell lymphoma incidence in Texas based on two different cancer registries.基于两个不同癌症登记处的德克萨斯州皮肤T细胞淋巴瘤发病率的人口统计学模式。
Cancer Med. 2015 Sep;4(9):1440-7. doi: 10.1002/cam4.472. Epub 2015 Jul 1.
4
Clustering of cutaneous T-cell lymphoma is associated with increased levels of the environmental toxins benzene and trichloroethylene in the state of Georgia.佐治亚州皮肤 T 细胞淋巴瘤的聚类与环境毒素苯和三氯乙烯水平升高有关。
Cancer. 2020 Apr 15;126(8):1700-1707. doi: 10.1002/cncr.32665. Epub 2020 Jan 14.
5
Non-random geographic distribution of patients with cutaneous T-cell lymphoma in the Greater Pittsburgh Area.匹兹堡大区皮肤T细胞淋巴瘤患者的非随机地理分布。
Dermatol Online J. 2014 Jul 15;20(7):13030/qt4nw7592w.
6
Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype.1992 年至 2011 年 CTCL 患者的第二原发恶性肿瘤:基于 SEER 的、基于人群的研究,评估 CTCL 诊断时的时间、年龄、性别、分期和 CD30+亚型。
Am J Clin Dermatol. 2016 Feb;17(1):71-7. doi: 10.1007/s40257-015-0155-3.
7
Association of airborne toxins with geographic clustering of cutaneous T-cell lymphoma in Louisiana.路易斯安那州空气中的毒素与皮肤T细胞淋巴瘤地理聚集性的关联。
J Am Acad Dermatol. 2022 Nov;87(5):1184-1186. doi: 10.1016/j.jaad.2022.03.003. Epub 2022 Mar 7.
8
Distribution and Clustering of Cutaneous T-Cell Lymphoma (CTCL) Cases in Canada During 1992 to 2010.1992 年至 2010 年期间加拿大皮肤 T 细胞淋巴瘤(CTCL)病例的分布和聚类。
J Cutan Med Surg. 2018 Mar/Apr;22(2):154-165. doi: 10.1177/1203475417745825. Epub 2017 Dec 14.
9
Geographic clustering of cutaneous T-cell lymphoma in New Jersey: an exploratory analysis using residential histories.新泽西州皮肤 T 细胞淋巴瘤的地理聚集性:利用居住史进行的探索性分析。
Cancer Causes Control. 2021 Sep;32(9):989-999. doi: 10.1007/s10552-021-01452-y. Epub 2021 Jun 12.
10
Primary cutaneous lymphomas: a population-based descriptive study of 71 consecutive cases diagnosed between 1980 and 2003.原发性皮肤淋巴瘤:一项基于人群的描述性研究,涉及1980年至2003年间连续诊断的71例病例。
Leuk Lymphoma. 2008 Aug;49(8):1537-44. doi: 10.1080/10428190802136368.

引用本文的文献

1
Role of Antigenic Stimulation in Cutaneous T-Cell Lymphomas.抗原刺激在皮肤 T 细胞淋巴瘤中的作用。
J Invest Dermatol. 2024 Apr;144(4):755-763. doi: 10.1016/j.jid.2023.10.023. Epub 2023 Dec 26.
2
Mycosis fungoides and Sézary syndrome: clinical presentation, diagnosis, staging, and therapeutic management.蕈样肉芽肿和塞扎里综合征:临床表现、诊断、分期及治疗管理
Front Oncol. 2023 Apr 14;13:1141108. doi: 10.3389/fonc.2023.1141108. eCollection 2023.
3
Disparities in Cutaneous T-Cell Lymphoma Incidence by Race/Ethnicity and Area-Based Socioeconomic Status.

本文引用的文献

1
Non-random geographic distribution of patients with cutaneous T-cell lymphoma in the Greater Pittsburgh Area.匹兹堡大区皮肤T细胞淋巴瘤患者的非随机地理分布。
Dermatol Online J. 2014 Jul 15;20(7):13030/qt4nw7592w.
2
Merkel cell carcinoma - recent advances in the biology, diagnostics and treatment.默克尔细胞癌——生物学、诊断与治疗的最新进展
Int J Biochem Cell Biol. 2014 Aug;53:536-46. doi: 10.1016/j.biocel.2014.04.023. Epub 2014 May 5.
3
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
按种族/族裔和基于区域的社会经济地位划分的皮肤 T 细胞淋巴瘤发病率的差异。
Int J Environ Res Public Health. 2023 Feb 17;20(4):3578. doi: 10.3390/ijerph20043578.
4
Epidemiologic Trends of Cutaneous T-Cell Lymphoma in Arkansas Reveals Demographic Disparities.阿肯色州皮肤T细胞淋巴瘤的流行病学趋势揭示了人口统计学差异。
Cancers (Basel). 2022 Sep 4;14(17):4329. doi: 10.3390/cancers14174329.
5
TOX Expression in Mycosis Fungoides and Sezary Syndrome.蕈样肉芽肿和塞扎里综合征中的TOX表达
Diagnostics (Basel). 2022 Jun 29;12(7):1582. doi: 10.3390/diagnostics12071582.
6
Association of Flame-Retardant Clothing With Mycosis Fungoides: A Retrospective Analysis.阻燃服装与蕈样肉芽肿的关联:一项回顾性分析。
Dermatol Pract Concept. 2022 Apr 1;12(2):e2022091. doi: 10.5826/dpc.1202a91. eCollection 2022 May.
7
Transcriptional Heterogeneity and the Microbiome of Cutaneous T-Cell Lymphoma.转录异质性与皮肤 T 细胞淋巴瘤的微生物组。
Cells. 2022 Jan 19;11(3):328. doi: 10.3390/cells11030328.
8
Geographic clustering of cutaneous T-cell lymphoma in New Jersey: an exploratory analysis using residential histories.新泽西州皮肤 T 细胞淋巴瘤的地理聚集性:利用居住史进行的探索性分析。
Cancer Causes Control. 2021 Sep;32(9):989-999. doi: 10.1007/s10552-021-01452-y. Epub 2021 Jun 12.
9
Epidemiology of Cutaneous T-Cell Lymphomas: A Systematic Review and Meta-Analysis of 16,953 Patients.皮肤T细胞淋巴瘤的流行病学:对16953例患者的系统评价和荟萃分析
Cancers (Basel). 2020 Oct 11;12(10):2921. doi: 10.3390/cancers12102921.
10
Hypopigmented Mycosis Fungoides: Loss of Pigmentation Reflects Antitumor Immune Response in Young Patients.色素减退性蕈样肉芽肿:色素脱失反映年轻患者的抗肿瘤免疫反应
Cancers (Basel). 2020 Jul 22;12(8):2007. doi: 10.3390/cancers12082007.
原发性皮肤 T 细胞淋巴瘤(蕈样肉芽肿和赛泽里综合征):第二部分。预后、治疗和未来方向。
J Am Acad Dermatol. 2014 Feb;70(2):223.e1-17; quiz 240-2. doi: 10.1016/j.jaad.2013.08.033.
4
Epidemiology of skin cancer: role of some environmental factors.皮肤癌的流行病学:一些环境因素的作用。
Cancers (Basel). 2010 Nov 24;2(4):1980-9. doi: 10.3390/cancers2041980.
5
Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis*.20 年来严重脓毒症患者死亡率趋势:一项比较性荟萃分析*。
Crit Care Med. 2014 Mar;42(3):625-31. doi: 10.1097/CCM.0000000000000026.
6
Age, race, sex, stage, and incidence of cutaneous lymphoma.年龄、种族、性别、分期和皮肤淋巴瘤的发病情况。
Clin Lymphoma Myeloma Leuk. 2012 Oct;12(5):291-6. doi: 10.1016/j.clml.2012.06.010.
7
Long-term outcomes of 1,263 patients with mycosis fungoides and Sézary syndrome from 1982 to 2009.1982 年至 2009 年间 1263 例蕈样肉芽肿和赛泽里综合征患者的长期预后。
Clin Cancer Res. 2012 Sep 15;18(18):5051-60. doi: 10.1158/1078-0432.CCR-12-0604. Epub 2012 Jul 31.
8
A meta-analysis of gene expression data identifies a molecular signature characteristic for tumor-stage mycosis fungoides.一项基因表达数据的荟萃分析确定了一个特征性的肿瘤期蕈样肉芽肿分子特征。
J Invest Dermatol. 2012 Aug;132(8):2050-9. doi: 10.1038/jid.2012.117. Epub 2012 Apr 19.
9
Infectious agents in cutaneous T-cell lymphoma.皮肤 T 细胞淋巴瘤中的感染因子。
J Am Acad Dermatol. 2011 Feb;64(2):423-31. doi: 10.1016/j.jaad.2009.11.692. Epub 2010 Aug 7.
10
Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors.蕈样肉芽肿和赛泽里综合征源于不同的 T 细胞亚群:其不同临床行为的生物学基础。
Blood. 2010 Aug 5;116(5):767-71. doi: 10.1182/blood-2009-11-251926. Epub 2010 May 18.